Depreciation of Esperion Therapeutics, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Esperion Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Esperion Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $26,000.
  • Esperion Therapeutics, Inc. annual Depreciation for 2025 was $105,000, a 67% increase from 2024.
  • Esperion Therapeutics, Inc. annual Depreciation for 2024 was $63,000, a 62% decline from 2023.
  • Esperion Therapeutics, Inc. annual Depreciation for 2023 was $164,000, a 67% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Esperion Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $105,000 +$42,000 +67% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $63,000 -$101,000 -62% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $164,000 -$336,000 -67% 01 Jan 2023 31 Dec 2023 10-K 10 Mar 2026 2025 FY
2022 $500,000 -$112,000 -18% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025 2024 FY
2021 $612,000 +$65,000 +12% 01 Jan 2021 31 Dec 2021 10-K 21 Feb 2023 2022 FY
2020 $547,000 +$228,000 +71% 01 Jan 2020 31 Dec 2020 10-K 22 Feb 2022 2021 FY
2019 $319,000 +$54,000 +20% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $265,000 +$7,000 +2.7% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $258,000 +$6,000 +2.4% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020 2019 FY
2016 $252,000 +$16,000 +6.8% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $236,000 +$76,000 +48% 01 Jan 2015 31 Dec 2015 10-K 20 Feb 2018 2017 FY
2014 $160,000 +$89,000 +125% 01 Jan 2014 31 Dec 2014 10-K 22 Feb 2017 2016 FY
2013 $71,000 -$68,000 -49% 01 Jan 2013 31 Dec 2013 10-K 25 Feb 2016 2015 FY
2012 $139,000 -$39,471 -22% 01 Jan 2012 31 Dec 2012 10-K 10 Mar 2015 2014 FY
2011 $178,471 01 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY

Esperion Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $26,000 +$26,000 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $0 -$81,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $81,000 -$72,000 -47% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $153,000 $0 0% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $153,000 +$47,000 +44% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $106,000 +$35,000 +49% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $71,000 +$10,000 +16% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $61,000 -$8,000 -12% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $69,000 +$5,000 +7.8% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $64,000 +$5,000 +8.5% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017 2017 Q1
Q1 2015 $59,000 +$47,000 +392% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $12,000 -$20,000 -62% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q1 2013 $32,000 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.